Comprehensive allergy immunotherapy operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the allergy immunotherapy field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.

Diagnostic technology development including molecular diagnostics, imaging systems, and point-of-care testing. This segment enables early disease detection and personalized medicine.